Skip to content

Noble Meta Alloy Coated Catheters in Patients With Long Term Catheterization

Noble Metal Alloy Coated Versus Silicone Foley Catheter in Patients With Long Term Catheterization: A Prospective Randomized Controlled Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04825314
Enrollment
100
Registered
2021-04-01
Start date
2020-05-21
Completion date
2021-06-21
Last updated
2021-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Catheter Infection, Catheter-Related Infections, Infection, Urinary Tract Infections

Keywords

catheter, UTI, Foley catheter, Nobel Metal Alloy catheter

Brief summary

Eighty percent of nosocomial UTI caused by indwelling urinary catheters and so known-as catheter-associated UTI. CAUTI leads to multiple local and systemic derangements such as suprapubic pain, dysuria, cystitis, pyelonephritis, septicemia, and even septic shock. This study will be conducted up on 100 patients (50 per each group) with long term catheterization to assess efficacy of noble metal alloy coated catheter in reducing CAUTI.

Detailed description

This prospective controlled randomized study conducted upon 100 patients at Alexandria University hospital from 21 May 2020 to 21 December 2020. Patients enrolled will be divided into two equal groups according to the urethral catheter inserted The institutional ethics committee for research approved the study. Written informed consent was obtained from all participants. In addition to taking the patients' medical history and completing general and physical examinations, physicians will choose proper catheter size all perform catheterization using aseptic technique according to guidelines of proper aseptic catheterization. Urologist ensures comparable catheter size and amount of balloon inflation. An aseptic non-touch technique (ANTT) must be used to obtain catheter specimen urine following these steps: * After catheterization apply clamp 10 cm distal to meatus then after few minutes clean the drainage port with alcohol and allow to dry then insert the syringe tip into the drainage port. * Three to five ml of urine collected in sterile disposable plastic cup at day zero (within 2 hours of catheterization), day ten and day twenty post catheterization. * The urine subjected to routine urine analysis, urine culture and sensitivity. Appropriate statistical tests will be used to indicate the frequency and type of CAUTI as well as to assess catheter tolerance in each arm, followed by a comparison to conclude the results.

Interventions

DEVICEUrethral catheter

All Patients will have urethral catheterization with either Noble Metal Alloy coated catheter or Silicon Foley catheter.

Sponsors

Alexandria University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

\- Patient under age of 80 years old who need prolonged urethral catheterization (more than 2 weeks) as a method of bladder drainage.

Exclusion criteria

* Patients with current or recent symptomatic urinary tract infection. * Antibiotic use currently or within 7 days prior to inclusion. * Known hypersensitivity to latex, silver salts or hydrogel. * Patients with recent surgical intervention in the urinary tract. * Patients with anatomic or functional upper urinary tract issues (e.g reflux, stones, etc.) * Uncontrolled DM. Patients on corticosteroid treatment. Immunosuppressed patients. Patients received pelvic irradiation.

Design outcomes

Primary

MeasureTime frameDescription
Urinary tract infection14 daysincidence of culture documented symotomatic urinary tract infection

Secondary

MeasureTime frameDescription
Catheter tolerance14 daysCatheter tolerance looks for discomfort or pain. Discomfort is an uncomfortable sensation due to the presence of a foreign object in the urethra without pain. The presence of actual pain is measured using VAS scoring system from zero to ten, so that a zero means no pain and a tenth means very severe pain.

Countries

Egypt

Contacts

Primary ContactTamer A Abou Youssif, MD
tamer.abouyoussif@alexmed.edu.eg+201101200076

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026